SOLV logo

SOLVENTUM CORP

SOLVNYSE
πŸ† #548 by market capEarnings Nov 4US Equity
$286.05β–² $11.99 (+4.19%)
πŸŒ™ After hours$84.10β–Ό 70.60%Simulated price
1hβ€”
24hβ–² 4.2%
7dβ–² 227.4%
14dβ–² 223.1%
30dβ–² 269.6%
1yβ–² 297.1%
🏦Market Cap
$14.50B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
-0.9%
Declining
πŸ“ŠGross Margin
54.8%
Healthy
πŸ’΅FCF Margin
2.1%
Thin
βš–οΈP/S Ratio
1.7x
Cheap
Otter Score
58
Weak

Trading Snapshot

Day Range
$281.61 – $291.71
52-Week Range
$62.38 – $90.00
Volume
$1.66B
Avg Volume
$2.14B
Shares Outstanding
173.2M
Next Earnings
Sep 28, 2026

Fundamentals Snapshot

Annual Revenue
$8.32B
Last Q Revenue
$2.21B
P/E Ratio
10.1
P/S Ratio
1.7x
EPS (TTM)
$8.19
Dividend Yield
β€”

Why Investors Own SOLV

  • βœ“High-growth profile β€” revenue up +5.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 45% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$8.32Bβ–² +4.4% YoY
Gross Margin (TTM)
45.2%β–² +1.9% YoY
Operating Income (TTM)
$699Mβ–² +4.4% YoY
Free Cash Flow (TTM)
$1.77Bβ–² +4.4% YoY

About SOLVENTUM CORP

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
58/100

Analyst Price Target

β“˜
Average Target
$373.99
β–² +30.7% Upside
High Target$470.73
Low Target$299.57
Based on 29 analysts

Latest News & Updates